Clinical Trial Update: Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants [Phase 1, Phase 2]

View source ↗

Summary

A gene transfer trial for X-linked severe combined immunodeficiency in newly diagnosed infants has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• X-linked Severe Combined Immunodeficiency

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Severe Combined Immunodeficiency Disease, X-linked | Phase 1, Phase 2 | Status: SUSPENDED